ACADIA PHARMACEUTICALS INC 004225108 05/29/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 BEONE MEDICINES LTD 07725L102 06/11/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in this Proxy Statement, for the fiscal year ended December 31, 2025 SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 CELCUITY INC 15102K100 05/14/2026 To approve, on an advisory basis, named executive officer compensation SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 CHIME FINL INC 16935C109 06/02/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 CHIME FINL INC 16935C109 06/02/2026 To select, on a non-binding advisory basis, whether future advisory votes on the compensation of our named executive officers should be held every one, two, or three years SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 HARMONY BIOSCIENCES HLDGS IN 413197104 05/14/2026 To consider and vote upon a proposal to approve on a non-binding, advisory basis, the compensation of our named executive officers ("say-on-pay") as described in our proxy materials SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 INCYTE CORP 45337C102 06/08/2026 Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 INSMED INC 457669307 05/13/2026 To conduct an advisory vote on the 2025 compensation of our named executive officers ("NEOs") SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 KYMERA THERAPEUTICS INC 501575104 06/24/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 MADRIGAL PHARMACEUTICALS INC 558868105 06/27/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the accompanying proxy statement; SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 PROCORE TECHNOLOGIES INC 74275K108 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 RECURSION PHARMACEUTICALS IN 75629V104 06/17/2026 To approve the compensation of our Named Executive Officers, as disclosed in the proxy statement accompanying this notice (Proposal 2) SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 REVOLUTION MEDICINES INC 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay") SECTION 14A SAY-ON-PAY VOTES 0 0 1 2 RHYTHM PHARMACEUTICALS INC 76243J105 06/24/2026 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("Say-on-Pay Vote") SECTION 14A SAY-ON-PAY VOTES 0 0 1 2